Companies: 10,795·Total market cap: $144.5T
Alumis Inc. Common Stock

Alumis Inc. Common Stock

ALMSNASDAQHealthcare● Active
$19.06
$-1.33(-6.52%)
Market Cap$2.4B
P/E Ratio
52W High$30.6
52W Low$2.76
Overview

Alumis Inc. Common Stock (ALMS) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ALMS · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.91alms eps ttm · alms earnings per shareEarnings history
PE Ratio (TTM)alms pe ratio ttm · alms price to earningsPE Ratio deep dive
Revenue (TTM)$8.4Malms revenue ttm · alms annual revenueFull revenue history
Dividend YieldNo Dividenddoes alms pay dividends · alms dividend yieldDividend history
Shares Outstanding850.3Malms shares outstanding · alms floatShares outstanding history
Next EarningsAug 12, 2026Est.alms earnings date · alms next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$24.1M
202320242025
alumis inc. common stock revenue · alms revenue 2025
FY 2025Net Income-$243.3M▲ +17.30% YoY
202320242025
alumis inc. common stock net income · alms profit 2025
FY 2025EPS$-2.86▲ +72.45% YoY
202320242025
alms eps · alumis inc. common stock earnings per share 2025
TTM:Revenue: $8.4MNet Income: -$237.4MEPS: $-1.91View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy8 analystsis alms a buy · alms analyst rating
Strong Buy
0
Buy
7
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$25.00Low
$19.06Current
$39.33Avg Target106.35% upside
$51.00High
alms price target · alms 12 month forecast

Total: 8 · Buy rate: 87.5%

The ALMS analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $39.33, representing +106.35% upside from the current price of $19.06.

Stock Performance

Full History
1D-6.52%
1W-5.74%
1M-19.44%
3M-29.14%
YTD+95.29%
1Y+455.69%
5Y+43.31%

About Alumis Inc. Common Stock

CEOMartin Babler
IPO DateFeb 22, 2021
Employees168
CountryUS
Websitealumis.com

Alumis Inc. Common Stock Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. It develops ESK-001, an allosteric tyrosine kinase 2 (T…

what is alumis inc. common stock · alms stock overview · alumis inc. common stock company profile · who is alumis inc. common stock ceo · alms NASDAQ · alumis inc. common stock headquarters · alumis inc. common stock business segments

About Stock Overview & Key Data

Alumis Inc. Common Stock (ALMS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 22, 2021. As of the latest trading session, ALMS stock price is $19.06, with a market capitalization of $2.4B. The stock has returned +455.69% over the past 12 months and +95.29% year-to-date.

According to 8 Wall Street analysts, the consensus rating for Alumis Inc. Common Stock stock is Buy, with an average 12-month price target of $39.33. In fiscal year 2025, Alumis Inc. Common Stock reported revenue of $24.1M and net income of -$243.3M. For detailed data — including Alumis Inc. Common Stock revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Alumis Inc. Common Stock (ALMS) stock price is $19.06. The stock is traded on NASDAQ under the ticker symbol ALMS. The 52-week range is $2.76 – $30.60.

ALMS stock priceALMS quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice